Tolerogenic therapy aims to induce immune tolerance in situations where the immune system is pathologically or undesirably activated. This can occur, for example, when a patient who has received an organ transplant develops an immune reaction against the donor's antigens, or when the body mounts an inappropriate response against its own tissues in an autoimmune disease. Research using animal models in transplantation and autoimmune disease has led to early-phase human trials of tolerogenic therapy for autoimmune conditions such as type 1 diabetes.
Facts
Connections
Treats
Source Tolerogenic therapy (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/Tolerogenic_therapy, lead sectionQuote, https://en.wikipedia.org/wiki/Tolerogenic_therapy, lead section
Tolerogenic therapy aims to induce immune tolerance where there is pathological or undesirable activation of the normal immune response.
Tolerogenic therapy (Wikipedia)
Treats: Type 1 Diabetes, Lead: treats Type 1 DiabetesQuote, Treats: Type 1 Diabetes, Lead: treats Type 1 Diabetes
Research using animal models in transplantation and autoimmune diseases has led to early-phase human trials of tolerogenic therapy for autoimmune conditions like Type 1 Diabetes.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.